1. Impact of switching to raltegravir and/or adding losartan in lymphoid tissue fibrosis and inflammation in people living with HIV. A randomized clinical trial. Issue 8 (20th July 2021) Authors: Torres, B; Guardo, AC; Squarcia, M; Diaz, A; Fabra, A; Caballero, M; Ugarte, A; Leal, L; Gatell, JM; Plana, M; Garcia, F Journal: HIV medicine Issue: Volume 22:Issue 8(2021) Page Start: 674 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗